24672634|t|Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients.
24672634|a|Oxidative stress involvement has been strongly hypothesized among the possible pathogenic mechanisms of motor neuron degeneration in amyotrophic lateral sclerosis (ALS). The intracellular redox balance is finely modulated by numerous complex mechanisms critical for cellular functions, among which the nuclear factor erythroid-derived 2-like 2 (NFE2L2/Nrf2) pathways. We genotyped, in a cohort of ALS patients (n = 145) and healthy controls (n = 168), three SNPs in Nrf2 gene promoter: -653 A/G, -651 G/A, and -617 C/A and evaluated, in a subset (n = 73) of patients, advanced oxidation protein products (AOPP), iron-reducing ability of plasma (FRAP), and plasma thiols (-SH) as oxidative damage peripheral biomarkers. Nrf2 polymorphisms were not different among patients and controls. Increased levels of AOPP (P < 0.05) and decreased levels of FRAP (P < 0.001) have been observed in ALS patients compared with controls, but no difference in -SH values was found. Furthermore, no association was found between biochemical markers of redox balance and Nrf2 polymorphisms. These data confirm an altered redox balance in ALS and indicate that, while being abnormally modified compared to controls, the oxidative stress biomarkers assessed in this study are independent from the -653 A/G, -651 G/A, and -617 C/A Nrf2 SNPs in ALS patients.
24672634	28	69	nuclear factor erythroid-derived 2-like 2	Gene	4780
24672634	133	162	amyotrophic lateral sclerosis	Disease	MESH:D000690
24672634	163	171	patients	Species	9606
24672634	277	302	motor neuron degeneration	Disease	MESH:D009410
24672634	306	335	amyotrophic lateral sclerosis	Disease	MESH:D000690
24672634	337	340	ALS	Disease	MESH:D000690
24672634	475	516	nuclear factor erythroid-derived 2-like 2	Gene	4780
24672634	518	524	NFE2L2	Gene	4780
24672634	525	529	Nrf2	Gene	4780
24672634	570	573	ALS	Disease	MESH:D000690
24672634	574	582	patients	Species	9606
24672634	639	643	Nrf2	Gene	4780
24672634	659	667	-653 A/G	DNAMutation	tmVar:c|SUB|A|-653|G;HGVS:c.-653A>G;VariantGroup:1;CorrespondingGene:4780;RS#:35652124;CorrespondingSpecies:9606;CA#:11038776
24672634	669	677	-651 G/A	DNAMutation	tmVar:c|SUB|G|-651|A;HGVS:c.-651G>A;VariantGroup:0;CorrespondingGene:4780;RS#:6706649;CorrespondingSpecies:9606;CA#:11091526
24672634	683	691	-617 C/A	DNAMutation	tmVar:c|SUB|C|-617|A;HGVS:c.-617C>A;VariantGroup:2;CorrespondingGene:4780;RS#:6721961;CorrespondingSpecies:9606;CA#:11132708
24672634	731	739	patients	Species	9606
24672634	785	789	iron	Chemical	MESH:D007501
24672634	836	842	thiols	Chemical	MESH:D013438
24672634	892	896	Nrf2	Gene	4780
24672634	936	944	patients	Species	9606
24672634	1058	1061	ALS	Disease	MESH:D000690
24672634	1062	1070	patients	Species	9606
24672634	1225	1229	Nrf2	Gene	4780
24672634	1292	1295	ALS	Disease	MESH:D000690
24672634	1449	1457	-653 A/G	DNAMutation	tmVar:c|SUB|A|-653|G;HGVS:c.-653A>G;VariantGroup:1;CorrespondingGene:4780;RS#:35652124;CorrespondingSpecies:9606;CA#:11038776
24672634	1459	1467	-651 G/A	DNAMutation	tmVar:c|SUB|G|-651|A;HGVS:c.-651G>A;VariantGroup:0;CorrespondingGene:4780;RS#:6706649;CorrespondingSpecies:9606;CA#:11091526
24672634	1473	1481	-617 C/A	DNAMutation	tmVar:c|SUB|C|-617|A;HGVS:c.-617C>A;VariantGroup:2;CorrespondingGene:4780;RS#:6721961;CorrespondingSpecies:9606;CA#:11132708
24672634	1482	1486	Nrf2	Gene	4780
24672634	1495	1498	ALS	Disease	MESH:D000690
24672634	1499	1507	patients	Species	9606
24672634	Association	RS#:6721961;HGVS:c.-617C>A;CorrespondingGene:4780	MESH:D000690
24672634	Association	RS#:6706649;HGVS:c.-651G>A;CorrespondingGene:4780	MESH:D000690
24672634	Association	RS#:35652124;HGVS:c.-653A>G;CorrespondingGene:4780	MESH:D000690
24672634	Association	MESH:D000690	4780

